相关实验视频

Updated: May 21, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

在低PD-L1 NSCLC病例中,对双重ICI与化疗的剧烈代谢反应

Toshikazu Kumasa1, Akina Nigi1, Keisuke Iwamoto1

  • 1Department of Respiratory Medicine Japanese Red Cross Ise Hospital Ise Japan.

Respirology case reports
|March 18, 2025
PubMed
概括

这项案例研究表明,对双重免疫检查点抑制剂和化疗有显著的反应,即使编程死亡连接体1 (PD-L1) 表达率低. 组合疗法可能会提供超出当前PD-L1选择标准的好处.

关键词:
在PET-CT中使用PET-CT.这里是 ipilimumab 的所在地.较低的PD-L1表达.肺癌是一种肺癌.这就是尼沃卢马布 (nivolumab).

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K